| Cytosol alanyl aminopeptidase | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Identifiers | |||||||||
| EC no. | 3.4.11.14 | ||||||||
| CAS no. | 243859-94-1 | ||||||||
| Databases | |||||||||
| IntEnz | IntEnz view | ||||||||
| BRENDA | BRENDA entry | ||||||||
| ExPASy | NiceZyme view | ||||||||
| KEGG | KEGG entry | ||||||||
| MetaCyc | metabolic pathway | ||||||||
| PRIAM | profile | ||||||||
| PDB structures | RCSB PDB PDBe PDBsum | ||||||||
| |||||||||
Cytosol alanyl aminopeptidase ( EC 3.4.11.14, arylamidase, aminopolypeptidase, thiol-activated aminopeptidase, human liver aminopeptidase, puromycin-sensitive aminopeptidase, soluble alanyl aminopeptidase, cytosol aminopeptidase III, alanine aminopeptidase) is an enzyme. [1] [2] [3]
This enzyme catalyses the release of an N-terminal amino acid, preferentially alanine, from a wide range of peptides, amides and arylamides.
This puromycin-sensitive enzyme is a Co2+-activated zinc- sialoglycoprotein.
References
- ^ Starnes WL, Behal FJ (July 1974). "A human liver aminopeptidase. The amino acid and carbohydrate content, and some physical properties of a sialic acid containing glycoprotein". Biochemistry. 13 (16): 3221–7. doi: 10.1021/bi00713a004. PMID 4841062.
- ^ Kao YJ, Starnes WL, Behal FJ (July 1978). "Human kidney alanine aminopeptidase: physical and kinetic properties of a sialic acid containing glycoprotein". Biochemistry. 17 (15): 2990–4. doi: 10.1021/bi00608a008. PMID 698181.
- ^ Sidorowicz W, Hsia WC, Maslej-Zownir O, Behal FJ (November 1980). "Multiple molecular forms of human alanine aminopeptidase: immunochemical properties". Clinica Chimica Acta; International Journal of Clinical Chemistry. 107 (3): 245–56. doi: 10.1016/0009-8981(80)90452-0. PMID 6108169.
External links
- Cytosol+alanyl+aminopeptidase at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
| Cytosol alanyl aminopeptidase | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Identifiers | |||||||||
| EC no. | 3.4.11.14 | ||||||||
| CAS no. | 243859-94-1 | ||||||||
| Databases | |||||||||
| IntEnz | IntEnz view | ||||||||
| BRENDA | BRENDA entry | ||||||||
| ExPASy | NiceZyme view | ||||||||
| KEGG | KEGG entry | ||||||||
| MetaCyc | metabolic pathway | ||||||||
| PRIAM | profile | ||||||||
| PDB structures | RCSB PDB PDBe PDBsum | ||||||||
| |||||||||
Cytosol alanyl aminopeptidase ( EC 3.4.11.14, arylamidase, aminopolypeptidase, thiol-activated aminopeptidase, human liver aminopeptidase, puromycin-sensitive aminopeptidase, soluble alanyl aminopeptidase, cytosol aminopeptidase III, alanine aminopeptidase) is an enzyme. [1] [2] [3]
This enzyme catalyses the release of an N-terminal amino acid, preferentially alanine, from a wide range of peptides, amides and arylamides.
This puromycin-sensitive enzyme is a Co2+-activated zinc- sialoglycoprotein.
References
- ^ Starnes WL, Behal FJ (July 1974). "A human liver aminopeptidase. The amino acid and carbohydrate content, and some physical properties of a sialic acid containing glycoprotein". Biochemistry. 13 (16): 3221–7. doi: 10.1021/bi00713a004. PMID 4841062.
- ^ Kao YJ, Starnes WL, Behal FJ (July 1978). "Human kidney alanine aminopeptidase: physical and kinetic properties of a sialic acid containing glycoprotein". Biochemistry. 17 (15): 2990–4. doi: 10.1021/bi00608a008. PMID 698181.
- ^ Sidorowicz W, Hsia WC, Maslej-Zownir O, Behal FJ (November 1980). "Multiple molecular forms of human alanine aminopeptidase: immunochemical properties". Clinica Chimica Acta; International Journal of Clinical Chemistry. 107 (3): 245–56. doi: 10.1016/0009-8981(80)90452-0. PMID 6108169.
External links
- Cytosol+alanyl+aminopeptidase at the U.S. National Library of Medicine Medical Subject Headings (MeSH)